Bruno, Peter M. http://orcid.org/0000-0003-3383-0118
Timms, Richard T. http://orcid.org/0000-0001-7275-597X
Abdelfattah, Nouran S.
Leng, Yumei
Lelis, Felipe J. N.
Wesemann, Duane R. http://orcid.org/0000-0002-6690-944X
Yu, Xu G.
Elledge, Stephen J. http://orcid.org/0000-0001-7923-6283
Article History
Received: 1 November 2021
Accepted: 13 October 2022
First Online: 2 January 2023
Competing interests
: S.J.E. is a founder of T-Scan Therapeutics, MAZE Therapeutics, ImmuneID and Mirimus, serves on the scientific advisory boards of Homology Medicines, ImmuneID, MAZE Therapeutics and T-Scan Therapeutics and is an advisor for MPM Capital, none of which affect this work. P.M.B. and S.J.E. are inventors of and have submitted a patent on the EpiScan technology. The remaining authors have no competing interests to declare.
Free to read: This content has been made available to all.